Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted based therapy in nodal T-cell lymphomas.

Leukemia - 1 Apr 2021

Chihara Dai, Miljkovic Milos, Iyer Swaminathan P, Vega Francisco

Abstract excerpt

T-cell lymphomas (TCL) are a group of biologically and clinically heterogenous neoplasms derived from mature T lymphocytes. Recent findings in biology have advanced the classification of these neoplasms; however, clinical investigations based on biologic features have yet to be designed. Two biomarker-driven treatments for TCL are promising: brentuximab vedotin (BV) in combination with chemotherapy or as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Management
Share to Disease Susceptibility
Share to Drug Approval

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Immunophenotyping

Share to Lymph Nodes

Share to Lymphoma, T-Cell

Share to Molecular Targeted Therapy

Source

Identifiers

PMID: 33664464
DOI: 10.1038/s41375-021-01191-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted based therapy in nodal T-cell lymphomas.PMID 33664464Read ↗

Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines.Semantic proximity Read ↗

Emerging strategies in peripheral T-cell lymphoma.Semantic proximity Read ↗

Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicabilitySemantic proximity Read ↗

T-cell Lymphomas: Updates in Biology and Diagnosis.Semantic proximity Read ↗

New targeted therapies for malignant lymphoma based on molecular heterogeneity.Semantic proximity Read ↗

Novel treatment for mantle cell lymphoma - impact of BTK inhibitors and beyond.Semantic proximity Read ↗

Targeting epigenetic regulators in the treatment of T-cell lymphoma.Semantic proximity Read ↗

Novel Therapeutics for Aggressive Non-Hodgkin's LymphomaSemantic proximity Read ↗

Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Case-Illustrated Narrative ReviewSemantic proximity Read ↗

The Future of Combination Therapies for Peripheral T Cell Lymphoma (PTCL).Semantic proximity Read ↗

Tumor mutation burden involving epigenetic regulatory genes and the RhoA GTPase predicts overall survival in nodal mature T-cell lymphomas.Semantic proximity Read ↗

Acalabrutinib May Offer a New Therapeutic Approach for Consolidation and Maintenance of Primary CNS Lymphoma with Expression of MYD88 and CD79B Gene Variants: A Case Report and Literature Review of Primary CNS Lymphoma in the BTKi EraSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.